BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19733963)

  • 1. The adenovirus-mediated linamarase/linamarin suicide system: a potential strategy for the treatment of hepatocellular carcinoma.
    Li J; Li H; Zhu L; Song W; Li R; Wang D; Dou K
    Cancer Lett; 2010 Mar; 289(2):217-27. PubMed ID: 19733963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The killing effect and bystander effect of linamarase/linamarin suicide gene system on human hepatocellular carcinoma cell line HepG2 in vitro].
    Chen MH; Ma J; Li HM; Li J; Li R; Zhang FQ; Dou KF
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Mar; 24(3):274-7. PubMed ID: 18328192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survivin knockdown by short hairpin RNA abrogates the growth of human hepatocellular carcinoma xenografts in nude mice.
    Zhang R; Ma L; Zheng M; Ren J; Wang T; Meng Y; Zhao J; Jia L; Yao L; Han H; Li K; Yang A
    Cancer Gene Ther; 2010 Apr; 17(4):275-88. PubMed ID: 19876077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
    Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
    Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyanide bystander effect of the linamarase/linamarin killer-suicide gene therapy system.
    Cortés ML; García-Escudero V; Hughes M; Izquierdo M
    J Gene Med; 2002; 4(4):407-14. PubMed ID: 12124983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An oncolytic adenoviral vector of Smac increases antitumor activity of TRAIL against HCC in human cells and in mice.
    Pei Z; Chu L; Zou W; Zhang Z; Qiu S; Qi R; Gu J; Qian C; Liu X
    Hepatology; 2004 May; 39(5):1371-81. PubMed ID: 15122766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel A33 promoter-based conditionally replicative adenovirus suppresses tumor growth and eradicates hepatic metastases in human colon cancer models.
    Cafferata EG; Macció DR; Lopez MV; Viale DL; Carbone C; Mazzolini G; Podhajcer OL
    Clin Cancer Res; 2009 May; 15(9):3037-49. PubMed ID: 19336523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased safety with preserved antitumoral efficacy on hepatocellular carcinoma with dual-regulated oncolytic adenovirus.
    Zhang Q; Chen G; Peng L; Wang X; Yang Y; Liu C; Shi W; Su C; Wu H; Liu X; Wu M; Qian Q
    Clin Cancer Res; 2006 Nov; 12(21):6523-31. PubMed ID: 17085667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of angiogenesis and HGF-cMET-elicited malignant processes in human hepatocellular carcinoma cells using adenoviral vector-mediated NK4 gene therapy.
    Heideman DA; Overmeer RM; van Beusechem VW; Lamers WH; Hakvoort TB; Snijders PJ; Craanen ME; Offerhaus GJ; Meijer CJ; Gerritsen WR
    Cancer Gene Ther; 2005 Dec; 12(12):954-62. PubMed ID: 15905856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful use of a plant gene in the treatment of cancer in vivo.
    Cortés ML; de Felipe P; Martín V; Hughes MA; Izquierdo M
    Gene Ther; 1998 Nov; 5(11):1499-507. PubMed ID: 9930303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of hepatocellular carcinoma with a novel gene-viral therapeutic system CNHK300-murine endostatin].
    Li GC; Nie MM; Yang JM; Su CQ; Sun LC; Qian YZ; Sham J; Fang GE; Wu MC; Qian QJ
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):943-8. PubMed ID: 15329284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic gene-directed enzyme prodrug therapy of hepatocellular carcinoma using a targeted adenovirus armed with carboxypeptidase G2.
    Schepelmann S; Hallenbeck P; Ogilvie LM; Hedley D; Friedlos F; Martin J; Scanlon I; Hay C; Hawkins LK; Marais R; Springer CJ
    Cancer Res; 2005 Jun; 65(12):5003-8. PubMed ID: 15958540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent antitumoral effects of a novel gene-viral therapeutic system CNHK300-mEndostatin in hepatocellular carcinoma.
    Li GC; Yang JM; Nie MM; Su CG; Sun LC; Qian YZ; Fang GE; Sham J; Wu MC; Qian QJ
    Chin Med J (Engl); 2005 Feb; 118(3):179-85. PubMed ID: 15740644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy of hepatocellular carcinoma in vitro and in vivo in nude mice by adenoviral transfer of the Escherichia coli purine nucleoside phosphorylase gene.
    Mohr L; Shankara S; Yoon SK; Krohne TU; Geissler M; Roberts B; Blum HE; Wands JR
    Hepatology; 2000 Mar; 31(3):606-14. PubMed ID: 10706550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenoviral oncolytic suicide gene therapy for a peritoneal dissemination model of gastric cancer in mice.
    Imamura Y; Ishikawa S; Sato N; Karashima R; Hirashima K; Hiyoshi Y; Nagai Y; Koga Y; Hayashi N; Watanabe M; Yamada G; Baba H
    Ann Surg Oncol; 2010 Feb; 17(2):643-52. PubMed ID: 20012217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined use of chemotherapeutics and oncolytic adenovirus in treatment of AFP-expressing hepatocellular carcinoma.
    Mao CY; Hua HJ; Chen P; Yu DC; Cao J; Teng LS
    Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):282-7. PubMed ID: 19502169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma.
    Blechacz B; Splinter PL; Greiner S; Myers R; Peng KW; Federspiel MJ; Russell SJ; LaRusso NF
    Hepatology; 2006 Dec; 44(6):1465-77. PubMed ID: 17133484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumoural immunity by virus-mediated immunogenic apoptosis inhibits metastatic growth of hepatocellular carcinoma.
    Boozari B; Mundt B; Woller N; Strüver N; Gürlevik E; Schache P; Kloos A; Knocke S; Manns MP; Wirth TC; Kubicka S; Kühnel F
    Gut; 2010 Oct; 59(10):1416-26. PubMed ID: 20675696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic antitumor activity of XIAP-shRNA and TRAIL expressed by oncolytic adenoviruses in experimental HCC.
    Pan Q; Liu B; Liu J; Cai R; Liu X; Qian C
    Acta Oncol; 2008; 47(1):135-44. PubMed ID: 17934893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.